BiotechTube

AmBisome

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Invasive Aspergillosis

Conditions

Invasive Aspergillosis, Other Fungal Infections

Trial Timeline

Apr 1, 2003 → Jan 1, 2005

NCT ID
NCT00158730

About AmBisome

AmBisome is a phase 3 stage product being developed by Gilead Sciences for Invasive Aspergillosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00158730. Target conditions include Invasive Aspergillosis, Other Fungal Infections.

What happened to similar drugs?

10 of 20 similar drugs in Invasive Aspergillosis were approved

Approved (10) Terminated (2) Active (9)
✅MicafunginAstellas PharmaApproved
✅caspofunginMerckApproved
✅SOC +Posaconazole 18 MG/ML (milligram/milliliter)MerckApproved
✅Caspofungin + Normal SalineMerckApproved
✅Ambisome + caspofunginGilead SciencesApproved
✅13-valent Pneumococcal conjugate vaccinePfizerApproved
✅voriconazolePfizerApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (4)

NCT IDPhaseStatus
NCT00670657ApprovedCompleted
NCT00326157Phase 2Completed
NCT00362544ApprovedCompleted
NCT00158730Phase 3Completed

Competing Products

20 competing products in Invasive Aspergillosis

See all competitors
ProductCompanyStageHype Score
BSG005Alkem LaboratoriesPhase 1/2
39
pegylated liposomal doxorubicin (PLD) + PD-1CSPC Pharmaceutical Group LimitedPhase 2
31
Trastuzumab deruxtecan + DurvalumabDaiichi SankyoPhase 2
42
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
40
Micafungin + fluconazoleAstellas PharmaPhase 3
40
MicafunginAstellas PharmaPre-clinical
26
Micafungin (Mycamine)Astellas PharmaPhase 1
29
Pudexacianinium chlorideAstellas PharmaPhase 2
35
Enfortumab vedotin + PembrolizumabAstellas PharmaPhase 2
42
Enfortumab Vedotin + PembrolizumabAstellas PharmaPhase 2
42
Isavuconazonium sulfate + Voriconazole + PosaconazoleAstellas PharmaPre-clinical
26
Pembrolizumab + Enfortumab VedotinAstellas PharmaPhase 3
44
Isavuconazonium sulfate + Isavuconazonium sulfateAstellas PharmaPhase 2
35
Micafungin + Systemic antifungal therapyAstellas PharmaPhase 2
27
MicafunginAstellas PharmaPre-clinical
26
Micafungin + PlaceboAstellas PharmaPhase 3
32
MicafunginAstellas PharmaApproved
35
Olorofim + AmBisome®ShionogiPhase 3
44
Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel + Epirubicin or doxorubicin, cyclophosphamide, paclitaxelJiangsu Hengrui MedicinePhase 3
44
SHR-A1811 + Trastuzumab EmtansineJiangsu Hengrui MedicinePhase 3
47